$2.13
-0.19-8.19%
At close: -
$2.14
0.010.47%
After Hours: 7:08 PM EDT
Comments
Loading...
Aclaris Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ACRS | Benzinga
Aclaris Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 6
EPS
$-0.120
Quarterly Revenue
$3.30M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$15.74M
Analyze the earnings history of Aclaris Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ACRS | Aclaris Therapeutics | -$0.11 | -$0.14 | -$0.12 | 14.29% | $4.35M | $1.48M | $3.30M | 123.03% | 11/06/2025 | |
ACRS | Aclaris Therapeutics | -$0.15 | -$0.13 | -$0.13 | 0.00% | $2.77M | $1.39M | $1.78M | 27.63% | 08/07/2025 | |
ACRS | Aclaris Therapeutics | -$0.24 | -$0.12 | -$0.12 | 0.00% | $2.40M | $4.78M | $1.46M | -69.56% | 05/08/2025 | |
ACRS | Aclaris Therapeutics | -$0.30 | -$0.27 | -$0.10 | 62.96% | $17.57M | $5.85M | $9.21M | 57.45% | 02/27/2025 | |
ACRS | Aclaris Therapeutics | -$0.41 | -$0.01 | -$0.11 | -1000.00% | $9.28M | $7.12M | $4.35M | -38.96% | 11/06/2024 | |
ACRS | Aclaris Therapeutics | -$0.42 | -$0.20 | -$0.15 | 25.00% | $1.87M | $1.82M | $2.77M | 51.98% | 08/07/2024 | |
ACRS | Aclaris Therapeutics | -$0.42 | -$0.29 | -$0.24 | 17.24% | $2.53M | $1.37M | $2.40M | 75.04% | 05/07/2024 | |
ACRS | Aclaris Therapeutics | -$0.41 | -$0.34 | -$0.30 | 11.76% | $7.75M | $3.36M | $17.57M | 422.92% | 02/27/2024 | |
ACRS | Aclaris Therapeutics | -$0.30 | -$0.48 | -$0.41 | 14.58% | $19.02M | $1.57M | $9.28M | 491.21% | 11/06/2023 | |
ACRS | Aclaris Therapeutics | -$0.31 | -$0.45 | -$0.42 | 6.67% | $1.53M | $1.90M | $1.87M | -1.63% | 08/07/2023 | |
ACRS | Aclaris Therapeutics | -$0.31 | -$0.44 | -$0.42 | 4.55% | $1.45M | $1.75M | $2.53M | 44.46% | 05/08/2023 | |
ACRS | Aclaris Therapeutics | -$0.37 | -$0.45 | -$0.41 | 8.89% | $1.50M | $1.99M | $7.75M | 289.60% | 02/23/2023 | |
ACRS | Aclaris Therapeutics | -$0.35 | -$0.40 | -$0.30 | 25.00% | $1.66M | $1.60M | $19.02M | 1088.62% | 11/08/2022 | |
ACRS | Aclaris Therapeutics | -$0.34 | -$0.36 | -$0.31 | 13.89% | $1.82M | $1.61M | $1.53M | -5.09% | 08/03/2022 | |
ACRS | Aclaris Therapeutics | -$0.57 | -$0.40 | -$0.31 | 22.50% | $1.78M | $1.66M | $1.45M | -12.47% | 05/10/2022 | |
ACRS | Aclaris Therapeutics | -$0.30 | -$0.36 | -$0.37 | -2.78% | $1.58M | $1.79M | $1.50M | -16.15% | 02/24/2022 | |
ACRS | Aclaris Therapeutics | -$0.25 | -$0.28 | -$0.35 | -25.00% | $1.45M | $1.77M | $1.66M | -6.27% | 11/02/2021 | |
ACRS | Aclaris Therapeutics | -$0.28 | -$0.29 | -$0.34 | -17.24% | $2.05M | $1.69M | $1.82M | 7.93% | 08/05/2021 | |
ACRS | Aclaris Therapeutics | -$0.37 | -$0.29 | -$0.57 | -96.55% | $1.41M | $1.69M | $1.78M | 5.15% | 05/07/2021 | |
ACRS | Aclaris Therapeutics | -$0.45 | — | -$0.30 | — | $1.09M | — | $1.58M | — | 02/25/2021 |
Aclaris Therapeutics (ACRS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.12 | $-0.14 | 14.3 % |
| Q2 | 2025-08-07 | $-0.13 | $-0.13 | 0.00 % |
| Q1 | 2025-05-08 | $-0.12 | $-0.12 | 0.00 % |
| Q4 | 2025-02-27 | $-0.10 | $-0.27 | 63.0 % |
Aclaris Therapeutics (ACRS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $3.30M | $1.48M | 123.0 % |
| Q2 | 2025-08-07 | $1.78M | $1.39M | 27.6 % |
| Q1 | 2025-05-08 | $1.46M | $4.78M | -69.6 % |
| Q4 | 2025-02-27 | $9.21M | $5.85M | 57.5 % |
FAQ
When is Aclaris Therapeutics (NASDAQ:ACRS) reporting earnings?
Aclaris Therapeutics (ACRS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3.
What were the latest earnings per share (EPS) for Aclaris Therapeutics (NASDAQ:ACRS)?
Aclaris Therapeutics (ACRS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3 and the Actual EPS was $-0.12, which beat the estimate of $-0.14.
What were Aclaris Therapeutics’s (NASDAQ:ACRS) revenues?
Aclaris Therapeutics (ACRS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2025 for Q3 and the Actual Revenue was $3.3M, which beat the estimate of $1.5M.
Browse earnings estimates, EPS, and revenue on all stocks.
